Press Releases (Page 84)
ADMA LEGAL NOTICE: ADMA Biologics, Inc. is being Investigated for Securities Fraud after Auditor Resignation; Investors with Losses are Urged to Contact BFA Law (Nasdaq:ADMA)
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s Stock Drop? ADMA... ❯❯❯
EXTR LAST DAY: The Deadline for Extreme Networks, Inc. Investors to ask the Court to Lead the Class Action is Today; Contact BFA Law if You Suffered Losses (Nasdaq:EXTR)
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Extreme Networks, Inc. (NASDAQ: EXTR) and certain of the Company’s senior executives. If you invested in Extreme, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/extreme-networks-inc. Investors have until October 15, 2024 to... ❯❯❯
Dolphin Claims Publishes Informative Article on How To Find The Best Public Adjusters In Florida
Fort Lauderdale, FL, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Dolphin Claims, an award-winning public adjustment service provider with an office in Miami, is excited to announce that its informative article on How To Find The Best Public Adjusters In Florida has recently been published to help home and business owners locate the ideal representative to secure fair settlements that reflect the true extent of their insurance losses. ... ❯❯❯
EXTR FINAL DEADLINE ALERT: A Securities Fraud Lawsuit was Filed against Extreme Networks, Inc.; Investors are Urged to Contact BFA Law before October 15 Court Deadline (Nasdaq:EXTR)
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Extreme Networks, Inc. (NASDAQ: EXTR) and certain of the Company’s senior executives. If you invested in Extreme, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/extreme-networks-inc. Investors have until October 15,... ❯❯❯
DXCM SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against DexCom, Inc.; Investors are Urged to Contact BFA Law before October 21 Court Deadline (Nasdaq:DXCM)
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October 21, 2024 to ask the Court to be... ❯❯❯
ELAN SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against Elanco Animal Health; Investors are Urged to Contact BFA Law before December 6 Court Deadline (NYSE:ELAN)
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/ela... ❯❯❯
ADMA SHAREHOLDER ALERT: ADMA Biologics, Inc. is Under Investigation for Securities Fraud after Auditor Resignation and 20% Stock Drop; Investors are Urged to Contact BFA Law (Nasdaq:ADMA)
NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s Stock Drop? ADMA... ❯❯❯
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outlook Therapeutics, Inc. (NASDAQ: OTLK) on behalf of long-term stockholders following a class action complaint that was filed against Outlook on November 3, 2023 with a Class Period from December 29, 2022 to August 29, 2023. Our investigation concerns whether the... ❯❯❯
UPS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against United Parcel Service, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against United Parcel Service, Inc. (“UPS” or the “Company”) (NYSE:UPS) in the United States District Court for the Northern District of Georgia on behalf of all persons and entities who purchased or otherwise acquired UPS securities between January 30, 2024... ❯❯❯
BEYOND ALERT: Bragar Eagel & Squire, P.C. is Investigating Beyond, Inc. on Behalf of Beyond Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Beyond, Inc. (“Beyond” or the “Company”) (NYSE:BYON) on behalf of Beyond stockholders. Our investigation concerns whether Beyond has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. ... ❯❯❯